Julian Panés

Jefe de la Unidad

jpanes@clinic.cat 0000-0002-4971-6902

Publicaciones destacadas

Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's disease

Autores: Ordás I, Rimola J, Alfaro I, Rodríguez S, Castro-Poceiro J, Ramírez-Morros A, Gallego M, Giner À, Barastegui R, Fernández-Clotet A, Masamunt M, Ricart E, Panés J .

Referencia: Gastroenterology 2019.
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease

Autores: Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Diez MC, Tagarro I, Leselbaum A, Danese S, ADMIRE CD Study Group Collaborators.

Referencia: Gastroenterology 2018.
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis

Autores: Dotti I., Mora-Buch R., Ferrer-Picón E., Planell N., Jung P., Masamunt M., Leal R., De Carpi J., Llach J., Ordás I., Batlle E., Panés J., Salas A..

Referencia: Gut 2017.
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.

Autores: Panés J, Sandborn WJ, Schreiber S, Sands BE, Vermeire S, D'Haens G, Panaccione R, Higgins PDR, Colombel JF, Feagan BG, Chan G, Moscariello M, Wang W, Niezychowski W, Marren A, Healey P, Maller E .

Referencia: Gut 2017.
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

Autores: Sandborn, William J.; Su, Chinyu; Sands, Bruce E.; D'Haens, Geert R.; Vermeire, Severine; Schreiber, Stefan; Danese, Silvio; Feagan, Brian G.; Reinisch, Walter; Niezychowski, Wojciech; Friedman, Gary; Lawendy, Nervin; Yu, Dahong; Woodworth, Deborah; Mukherjee, Arnab; Zhang, Haiying; Healey, Paul; Panes, Julian;OCTAVE Induction 1 OCTAVE Inductio.

Referencia: New England Journal Of Medicine 2017.
Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease

Autores: Jauregui-Amezaga A, Rovira M, Marín P, Salas A, Pinó-Donnay S, Feu F, Elizalde JI, Fernández-Avilés F, Martínez C, Gutiérrez G, Rosiñol L, Carreras E, Urbano A, Lozano M, Cid J, Suárez-Lledó M, Mensa J, Rimola J, Rodríguez S, Masamunt MC, Comas D, Ruíz I, Ramírez-Morros A, Gallego M, Ordás I, Panés J, Ricart E .

Referencia: Gut 2016.
Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile

Autores: Calderon-Gomez, Elisabeth; Bassolas-Molina, Helena; Mora-Buch, Rut; Dotti, Isabella; Planell, Nuria; Esteller, Miriam; Gallego, Marta; Marti, Merce; Garcia-Martin, Carme; Martinez-Torro, Carlos; Ordas, Ingrid; Singh, Sharat; Panes, Julian; Benitez-Ribas, Daniel; Salas, Azucena;.

Referencia: Gastroenterology 2016.
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: A phase 3 randomised, double-blind controlled trial

Autores: Panes J; Garcia-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S.

Referencia: Lancet 2016.
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease

Autores: Rimola, J; Rodriguez, S; Garcia-Bosch, O; Ordas, I; Ayala, E; Aceituno, M; Pellise, M; Ayuso, C; Ricart, E; Donoso, L; Panes, J.

Referencia: Gut 2009.

Proyectos destacados

Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)

Investigador/a principal: Maria Azucena Salas Martinez, Julian Panes Diaz

Financiador: Ministerio de Ciencia, Innovación y Universidades (Programa financiador competitivo)

Código: RTI2018-096946-B-I00

Duración: 01/01/2019 - 31/12/2021
Efficacy and safety of autologous hematopoietic stem cells transplantation for refractory Crohn's disease

Investigador/a principal: Elena Ricart

Financiador: Instituto de Salud Carlos III (Programa financiador competitivo)

Código: PI17/00513

Duración: 01/01/2018 - 31/12/2020
IBD over time: Cellular Mechanisms in Crohn’s Disease Revealing new therapeutic avenues

Investigador/a principal: Maria Azucena Salas Martinez

Financiador: The Leona M and Harry B Helmsley Charitable Trust

Código: Hemsley

Duración: 02/01/2014 - 31/12/2017
New siRNA nanotherapy for inflammatory bowel diseases, targeting Janus kinase 3

Investigador/a principal: Fabrice Navarro, Maria Azucena Salas Martinez, Julian Panes Diaz

Código: NEW DEAL H2020

Duración: 01/01/2017 - 31/12/2020
Autologous Hematopoietic Stem Cell Transplant in Crohn's Disease: genetic, Immune and Microbiome factors involved in disease control (TrIM)

Investigador/a principal: Julian Panes Diaz

Código: SAF 2012-33560

Duración: 02/01/2013 - 31/12/2015

Julian Panés

Publicaciones destacadas

Proyectos destacados

Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)

Efficacy and safety of autologous hematopoietic stem cells transplantation for refractory Crohn's disease

IBD over time: Cellular Mechanisms in Crohn’s Disease Revealing new therapeutic avenues

New siRNA nanotherapy for inflammatory bowel diseases, targeting Janus kinase 3

Autologous Hematopoietic Stem Cell Transplant in Crohn's Disease: genetic, Immune and Microbiome factors involved in disease control (TrIM)

Suscríbete a la Newsletter del Clínic